| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.38.5.720 |
| P953 | full work available at URL | https://journals.lww.com/10.1212/WNL.38.5.720 |
| P698 | PubMed publication ID | 3362368 |
| P2093 | author name string | J. R. Atack | |
| D. L. Price | |||
| R. Mayeux | |||
| K. J. Kellar | |||
| P. J. Whitehouse | |||
| A. M. Martino | |||
| M. V. Wagster | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 720-723 | |
| P577 | publication date | 1988-05-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autobiographic study | |
| Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study | |||
| P478 | volume | 38 |
| Q42471486 | A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam |
| Q34747831 | A summary risk score for the prediction of Alzheimer disease in elderly persons |
| Q52050224 | Acute and chronic nicotine effects on working memory in aged rats. |
| Q47949529 | Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. |
| Q48031078 | Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus |
| Q68576322 | Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis |
| Q34160761 | Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies |
| Q34327937 | An update on brain imaging in parkinsonian dementia |
| Q73222827 | Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease |
| Q48253436 | Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus |
| Q48654715 | Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease |
| Q21131066 | Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease |
| Q34496928 | Brain imaging of nicotinic receptors in Alzheimer's disease |
| Q48934855 | Cell membrane changes in brains manifesting senile plaques: an immunohistochemical study of GM1 membranous ganglioside |
| Q34002742 | Central nicotinic receptors, neurotrophic factors and neuroprotection |
| Q37709932 | Cholinergic dysfunction in Parkinson's disease |
| Q26764933 | Cholinergic imaging in dementia spectrum disorders |
| Q38016639 | Cholinergic receptors in the rat and human brain: microscopic visualization |
| Q40783837 | Cholinergic systems: human diseases, animal models, and prospects for therapy. |
| Q45985006 | Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease. |
| Q34002779 | Development of ligands for in vivo imaging of cerebral nicotinic receptors |
| Q64093859 | Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes |
| Q37160197 | Effect of smoking and time on cognitive function in the elderly without dementia |
| Q52052861 | Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze |
| Q47740460 | Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats |
| Q26865371 | Epidemiology of Alzheimer disease |
| Q48432372 | Free fatty acid derivative HUHS2002 potentiates α7 ACh receptor responses through indirect activation of CaMKII. |
| Q27013767 | Functional neuroimaging in Parkinson's disease |
| Q46299076 | Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. |
| Q40515562 | Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease |
| Q47616063 | Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel |
| Q43942893 | Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory |
| Q29397943 | Human neuronal nicotinic receptors |
| Q36743706 | Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders |
| Q48094212 | Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions. |
| Q36875915 | Immune effects and antiacetylcholinesterase activity of Polygonum hydropiper L. |
| Q35534317 | Immunohistochemistry of cholinergic receptors |
| Q36268875 | Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease |
| Q28505103 | Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors |
| Q52044821 | Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? |
| Q47775093 | Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography |
| Q42442234 | Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients |
| Q49065531 | Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood |
| Q36724965 | Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease |
| Q44269773 | Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease |
| Q53237072 | Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance. |
| Q28141480 | Neuronal nicotinic receptors in the human brain |
| Q34995021 | Nicotine and nicotinic receptors; relevance to Parkinson's disease |
| Q73634969 | Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurons |
| Q36932233 | Nicotinic Cholinergic Receptors in Human Brain: Effects of Aging and Alzheimer |
| Q44573142 | Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. |
| Q35790283 | Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtype. |
| Q40692719 | Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons |
| Q41330522 | Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity. |
| Q48618915 | Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats |
| Q53189482 | Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. |
| Q51424143 | Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. |
| Q36882136 | Nicotinic receptors as CNS targets for Parkinson's disease |
| Q52081673 | Nicotinic systems and cognitive function |
| Q33919793 | Nicotinic systems in central nervous systems disease: degenerative disorders and beyond |
| Q34002775 | Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. |
| Q32077243 | Nicotinic treatment of Alzheimer's disease |
| Q37825631 | Parkinson's disease dementia and potential therapeutic strategies |
| Q73045276 | Quantitative structure-activity relationships of nicotine analogues as neuronal nicotinic acetylcholine receptor ligands |
| Q44225345 | Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. |
| Q48181250 | Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. |
| Q48124513 | Subunit and region-specific decreases in nicotinic acetylcholine receptor mRNA in the aged rat brain |
| Q33922186 | The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors |
| Q37671065 | The cholinergic system and Parkinson disease |
| Q38016651 | The cholinergic system in Alzheimer disease |
| Q34441061 | The cholinergic system in Alzheimer's disease |
| Q44021007 | The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors |
| Q44366548 | The newly synthesized linoleic acid derivative FR236924 induces a long-lasting facilitation of hippocampal neurotransmission by targeting nicotinic acetylcholine receptors |
| Q48337088 | Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats |
Search more.